|
|
|
|
|
|
|
|
|
|
|
|
|
17.11.25 - 14:09
|
Sonoma Biotherapeutics Announces Transition of Jeff Bluestone, PhD, to Advisor; Appoints Stephen Dilly, MBBS, PhD, as President and Chief Executive Officer (Business Wire)
|
|
|
Dr. Bluestone to serve as Advisor to the Company and remain on Board of Directors
Dr. Dilly to bring track record in biopharmaceutical leadership, business development and drug development to new leadership role
CEO transition to drive next stage of growth following positive first-in-human data from SBT-77-7101 trial
SOUTH SAN FRANCISCO, Calif. & SEATTLE--(BUSINESS WIRE)--Sonoma Biotherapeutics, Inc., a clinical-stage biotechnology company developing engineered regulatory T cell (Treg) therapies for autoimmune and inflammatory diseases, today announced that its Board of Directors has appointed Stephen Dilly, MBBS, PhD, former President and Chief Executive Officer (CEO) of Codexis, Inc., and current Chair of the Codexis Board, as the Company's new President, CEO and member of the Board of Directors, effective today. The Company also announced that co-founder Jeff Bluestone, PhD, will continue to serve as a member of the Board of Directors and as Advisor to SonomaBio, following his leadership in the Compan...
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
10.11.25 - 15:03
|
Codexis Announces Signing of Lease for GMP Manufacturing Facility (GlobeNewswire EN)
|
|
|
REDWOOD CITY, Calif., Nov. 10, 2025 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading provider of enzymatic solutions for the efficient and scalable manufacturing of complex therapeutics, today announced that it has signed a lease for a 34,000 square foot GMP manufacturing facility in Hayward, California....
|
|
|
|
|
|
|
|
|
|
|
23.10.25 - 13:09
|
Codexis to Report Third Quarter 2025 Financial Results on November 6 (GlobeNewswire EN)
|
|
|
REDWOOD CITY, Calif., Oct. 23, 2025 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading provider of enzymatic solutions for the efficient and scalable manufacturing of complex therapeutics, today announced that it will report its financial results for the third quarter of 2025 on Thursday, November 6, 2025, following the close of market. Codexis management will host a conference call and webcast at 4:30 pm Eastern Time to discuss the Company's financial results and provide a business update....
|
|
|
|
Börsentreff auf Facebook |
Börsentreff auf X |
Börsentreff auf Instagram
